Bookimed does not add extra charges for Immunotherapy with Keytruda (Pembolizumab) prices. The rates come from the clinics' official price lists. You pay directly at the clinic for your Immunotherapy with Keytruda (Pembolizumab) upon your arrival.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Immunotherapy with Keytruda (Pembolizumab) and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Immunotherapy with Keytruda (Pembolizumab) journey.
The USA | Turkey | Mexico | |
Immunotherapy with Keytruda (Pembolizumab) | from $21900 | from $7300 | from $8395 |
Memorial Şişli Hospital in Istanbul is the largest multidisciplinary medical center offering high quality treatment. It has specialties in oncology, bone marrow transplant, in vitro fertilization (IVF), neurosurgery, and organ transplant with a success rate of 90%. The clinic is well respected among patients from 92 countries and is accredited by the Joint Commission International for its quality of care. It offers Immunotherapy with Keytruda (Pembolizumab) procedure in Turkey, under the supervision of its experienced doctor, Dr. Serkan Keskin, who has been working since 2001. The procedure includes consumable materials, follow-up examination, preoperative tests, consultation with a doctor, transfer airport-clinic-airport, individual chamber, transfer airport-hotel-clinic-airport and accommodation is not included. It will take 0 days stay in the hospital and 1 day stay in the hotel. For more information, visit the Memorial Şişli Hospital website.
Medicana Ataşehir Hospital is one of the multispecialty hospitals of Medicana Group of Hospitals in Turkey. It comprises 12 modern clinics and employs over 3,500 medical personnel following world’s standards of treatment.
Medicana Ataşehir Hospital meets quality and service standards of the Turkish Ministry of Health and the Joint Commission International (JCI).
Day 1
Day 2
Day 3
Day 4-5
Day 6
Day 7
Weeks 2-4
Please note that each patient"s experience may vary, and you should always follow the advice of your healthcare provider.
What patients like:
What patients don't like:
Prof. Baytan is a doctor who graduated from Ankara University Medical Faculty in 1992 and became a Specialist in Medicine at Uludağ University Faculty of Medicine, Department of Child Diseases. He is experienced in the diagnosis and treatment of childhood cancers, leukemia, anemia, and other diseases. He has 15 articles published in international refereed journals, 9 full texts presented and published in international scientific meetings, 3 books/book chapters written, and 8 articles published in local refereed journals.
Keytruda, a form of immune-based therapy, leverages the body's immune system to target and destroy cancer cells using monoclonal antibodies.